RGNX REGENXBIO Inc.
$6.13▼ -3.31%
Unknown
Other
Last sync: just now
Syncing
Key Metrics & Fundamentals
Market Cap
$316.91M
P/E Ratio
–
Div Yield
–%
52W Range
5.46 - 16.19
% vs 50 MA
-22.38%
% vs 200 MA
-39.10%
RSI-14
40.5
MACD Histogram
+0.0200
Beta (1Y vs SPY)
2.41
Free Cash Flow
-$77.42M
Gross Rev
$6.39M
Gross Profit
-$4.68M
EBITDA
-$79.49M
COGS
$11.07M
Operating Exp
$78.68M
Operating Income
-$83.36M
EBIT
-$83.36M
Pretax Income
-$90.05M
Net Income
-$90.05M
EPS (Diluted)
-1.72
Price & Volume History
Volume (M)
Financial Overview - Income Statement
Quarterly
Mar 2026 (Quarterly)
Social Sentiment
Avg +0.75 · 2 posts
DiscussionFavorite mid-cap biotech with the most upside? (500M–2.5B mkt cap)
r/investing · Dec 22, 2025
Mentioned as a potential investment, and a point of discussion.
positive
+0.70
Ripe for picking - (FDMT) 4D Molecular Therapeutics?
r/stocks · Oct 20, 2024
The post presents a highly optimistic financial model and potential for RGNX, driven by the promising 4D-150 drug candidate.
positive
+0.80
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not Financial Advice.
All data, scores, charts, and analysis on this site are provided for informational and educational purposes only
and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
Always consult a qualified financial advisor before making any investment decisions.
See our Legal Notice for full details.